TR201714728A1 - Dry powder formulation containing Beta-2 Agonist and Corticosteroid. - Google Patents

Dry powder formulation containing Beta-2 Agonist and Corticosteroid. Download PDF

Info

Publication number
TR201714728A1
TR201714728A1 TR2017/14728A TR201714728A TR201714728A1 TR 201714728 A1 TR201714728 A1 TR 201714728A1 TR 2017/14728 A TR2017/14728 A TR 2017/14728A TR 201714728 A TR201714728 A TR 201714728A TR 201714728 A1 TR201714728 A1 TR 201714728A1
Authority
TR
Turkey
Prior art keywords
dry powder
corticosteroid
agonist
formulation containing
powder formulation
Prior art date
Application number
TR2017/14728A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi filed Critical Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/14728A priority Critical patent/TR201714728A1/en
Publication of TR201714728A1 publication Critical patent/TR201714728A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, formoterol ve budezonidden oluşan, kuru toz formundaki farmasötik formülasyonlara ilişkindir.The present invention relates to pharmaceutical formulations in dry powder form comprising formoterol and budezonide for use in respiratory tract disorders.

TR2017/14728A 2017-09-30 2017-09-30 Dry powder formulation containing Beta-2 Agonist and Corticosteroid. TR201714728A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2017/14728A TR201714728A1 (en) 2017-09-30 2017-09-30 Dry powder formulation containing Beta-2 Agonist and Corticosteroid.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/14728A TR201714728A1 (en) 2017-09-30 2017-09-30 Dry powder formulation containing Beta-2 Agonist and Corticosteroid.

Publications (1)

Publication Number Publication Date
TR201714728A1 true TR201714728A1 (en) 2019-04-22

Family

ID=67979851

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/14728A TR201714728A1 (en) 2017-09-30 2017-09-30 Dry powder formulation containing Beta-2 Agonist and Corticosteroid.

Country Status (1)

Country Link
TR (1) TR201714728A1 (en)

Similar Documents

Publication Publication Date Title
MA55571A (en) PHARMACEUTICAL COMPOSITIONS COMPRISING N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1, 2-DIAMINE
CY1120684T1 (en) DRY DUST PREPARATION THAT CONTAINS A CORTICOSTEROIDS AND A BETA-ADRENERGIC FOR INHALATION
PH12018500586A1 (en) Farnesoid x receptor agonists and uses thereof
EP3630145A4 (en) Pharmaceutical compositions comprising cannabidiol and beta-caryophyllene and methods for their use
JP2015096530A5 (en)
BR112015018087A8 (en) compound, pharmaceutical composition and use
CY1124490T1 (en) A PROCESS FOR THE PREPARATION OF A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC
CO2019008103A2 (en) Pharmaceutical compositions for combination therapy
MX2015015132A (en) Inhalable pharmaceutical compositions and the inhaler devices containing them.
BR112017009510A2 (en) compositions comprising cyclosporine
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
CO2018014217A2 (en) Pharmaceutical compositions comprising safinamide
PH12018502139A1 (en) Phosphaplatin liquid formulations
TR201714728A1 (en) Dry powder formulation containing Beta-2 Agonist and Corticosteroid.
TR201714893A1 (en) Dry powder composition containing Beta-2 Agonist and Corticosteroid.
TR201714725A1 (en) DRY POWDER FORMULATION WITH BETA-2 AGONIST AND ANTICOLINERGIC
CO2017003989A2 (en) Herbicidal composition and process to prepare it
TR201716155A1 (en) Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist.
IL284587A (en) Pharmaceutical composition comprising antibody, device comprising same, and use thereof
TR201716207A2 (en) Pharmaceutical formulations containing vilanterol and umeclidinium.
MX2019015869A (en) New oral formulations of belinostat.
EP3898596C0 (en) Pharmaceutical compound, the method of its making and use as medicinal agent
TR200907913A2 (en) Pharmaceutical composition in dry powder form for inhalation
PH12018501991A1 (en) Pharmaceutical composition for use in treating fibrosis
EP3733176A4 (en) Composition comprising piperacillin, pharmaceutical preparation thereof and use thereof